Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

Bullboard Posts

Comment by demarkoon Mar 31, 2008 5:38pm

397 Views

Post# 14924223

RE: Resources

YES , the new SH is brutal. I feel like im on dial again. I hope they fix it.

All i know about HLO is they have been putting themselves out there, at all different mining shows etc. The SP is dogging allot, and so is the market. But like you said, news and there 2nd 43-101 in 6mnths and no attention? Maybe they need to hire a new PR person to attract investors.

whats your thoughts?

Bullboard Posts

How one company is disrupting PoC testing